Harwood Feffer LLP Announces Investigation of Arena Pharmaceuticals, Inc.

NEW YORK, Oct. 7, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Arena Pharmaceuticals, Inc. ("Arena" or the "Company") (NASDAQ: ARNA), concerning whether the board has breached its fiduciary duties to shareholders.

On October 5, 2015, the Company announced that, at the request of the board, Jack Lief was retiring as Chief Executive Officer and as a member of the board.  The Company further announced that it was assessing plans for 2016 following the Company losing a third of its value after it announced its second-quarter earnings results.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Arena shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Daniella Quitt, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email:  bsachsmichaels@hfesq.com
Website:   http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 

 

SOURCE Harwood Feffer LLP